beta
(영문) 서울중앙지방법원 2020.12.03 2018가단5177826

채무부존재확인

Text

The plaintiff (the plaintiff-Counterclaim defendant) stated the "amount of recognition" in the attached Table to the defendants (including the plaintiff-Counterclaim N Co., Ltd.).

Reasons

1. Basic facts

A. The plaintiff (Counterclaim defendant; hereinafter the plaintiff) Gap, the representative director of Q oriental medicine hospital (hereinafter "the hospital of this case") in Gyeyang-gu in Incheon, the non-party L, the doctor employed by the hospital of this case and working as the head of the bilateral bank, and the non-party S, the plaintiff (Counterclaim defendant; hereinafter "the plaintiff"), the plaintiff (the counter-party defendant; hereinafter "the plaintiff") Eul, the plaintiff (the counter-party defendant; hereinafter "the plaintiff") who was in charge of the fluid tons treatment at the hospital of this case, shall be the person who assisted the fluid tons treatment at the hospital of this case as the owner of the fluid tons treatment device of this case.

(b) Ton treatment is treatment that has not been assessed by the Committee on the Evaluation of New Medical Technology so that it is impossible to receive medical expenses from patients, as well as that it is not subject to a claim for reimbursement for actual expenses, and even if a policyholder purchases indemnity insurance, it cannot be guaranteed actual expenses.

C. The plaintiffs and the above non-party changed the name "StA" or "DOSU-B" ("DOSU-B") to provide the patients who were admitted to the hospital or hospitalized at the hospital of this case with the insurance company that they subscribed to receive reimbursement for actual expenses from the insurance company. The plaintiffs and the above non-party changed the name "StU-A" or "DOSU-B" ("DOSU-B" after 2 months) to "St treatment" ("each set of this case" hereinafter). The defendant A instructed the patients to issue necessary documents, such as a detailed statement of medical expenses without a dosen treatment, so that they can claim reimbursement for actual expenses for each set of this case from the insurance company that they subscribed to the hospital of this case. The deceased R prescribed each set of this case for medical treatment to patients, and the medical examination and treatment of the insurance company can claim for actual expenses from the insurance company without prescribing the amount of insurance company's prescription "FOSU-1" or "DOSU-B".